These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 30864719)
21. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression. Han LL; Yin XR; Zhang SQ Cell Physiol Biochem; 2018; 51(3):1179-1192. PubMed ID: 30481780 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer. Wang C; Tao W; Ni S; Chen Q J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179 [TBL] [Abstract][Full Text] [Related]
24. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532 [TBL] [Abstract][Full Text] [Related]
25. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma. Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685 [TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
27. Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a. Yan X; Zhang D; Wu W; Wu S; Qian J; Hao Y; Yan F; Zhu P; Wu J; Huang G; Huang Y; Luo J; Liu X; Liu B; Chen X; Du Y; Chen R; Fan Z Cancer Res; 2017 Dec; 77(23):6704-6716. PubMed ID: 28947421 [TBL] [Abstract][Full Text] [Related]
28. GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells. Li SS; Chen DM; Chen LB; Wei H; Wang JL; Xiao J; Huang YH; Lian YF Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880590 [TBL] [Abstract][Full Text] [Related]
29. Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma. Zhu P; Lv J; Yang Z; Guo L; Zhang L; Li M; Han W; Chen X; Zhuang H; Lu F Biochem Biophys Res Commun; 2014 Sep; 452(3):567-74. PubMed ID: 25172662 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
32. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408 [TBL] [Abstract][Full Text] [Related]
33. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
34. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208 [TBL] [Abstract][Full Text] [Related]
35. MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1. Li T; Li M; Hu S; Cheng X; Gao Y; Jiang S; Yu Q; Zhang C; Sun P; Xian W; Song Z; Zhang Y; Zheng Q Int J Biol Macromol; 2017 Oct; 103():1054-1061. PubMed ID: 28539268 [TBL] [Abstract][Full Text] [Related]
36. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1. He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578 [TBL] [Abstract][Full Text] [Related]
37. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. Karaosmanoğlu O; Banerjee S; Sivas H Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962 [TBL] [Abstract][Full Text] [Related]
38. miR-1306-3p targets FBXL5 to promote metastasis of hepatocellular carcinoma through suppressing snail degradation. He ZJ; Li W; Chen H; Wen J; Gao YF; Liu YJ Biochem Biophys Res Commun; 2018 Oct; 504(4):820-826. PubMed ID: 30219228 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA. Jin Y; Wu D; Yang W; Weng M; Li Y; Wang X; Zhang X; Jin X; Wang T Virol J; 2017 Dec; 14(1):238. PubMed ID: 29258558 [TBL] [Abstract][Full Text] [Related]
40. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver. Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]